ArticleJournal of molecular medicine (Berlin, Germany)2025

Targeted metabolomics reveals tricarboxylic acid cycle-related metabolites serve as predictive biomarkers for trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer.

Ting Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.